Levothyroxine sodium revisited: A wholistic structural elucidation approach of new impurities via HPLC-HRMS/MS, on-line H/D exchange, NMR spectroscopy and chemical synthesis
[Display omitted] •A multitude of levothyroxine sodium impurities new to literature are characterized via HPLC-HRMS/MS and On-line H/D exchange.•5 major LT4 impurities are identified via synthesis or isolation of the reference substance and characterization with 1D and 2D-NMR.•CID fragmentation mech...
Gespeichert in:
Veröffentlicht in: | Journal of pharmaceutical and biomedical analysis 2017-02, Vol.135, p.140-152 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | [Display omitted]
•A multitude of levothyroxine sodium impurities new to literature are characterized via HPLC-HRMS/MS and On-line H/D exchange.•5 major LT4 impurities are identified via synthesis or isolation of the reference substance and characterization with 1D and 2D-NMR.•CID fragmentation mechanisms of identified levothyroxine sodium impurities are discussed.•New subclasses of levothyroxine sodium impurities are introduced originating from the alternative synthetic route of this API.
The structural elucidation of unknown pharmaceutical impurities plays an important role in the quality control of newly developed and well-established active pharmaceutical ingredients (APIs). The United States Pharmacopeia (USP) monograph for the API Levothyroxine Sodium, a synthetic thyroid hormone, features two high pressure liquid chromatography (HPLC) methods using UV-VIS absorption detection to determine organic impurities in the drug substance. The impurity profile of the first USP method (“Procedure 1”) has already been extensively studied, however for the second method (“Procedure 2”), which exhibits a significantly different impurity profile, no wholistic structural elucidation of impurities has been performed yet. Applying minor modifications to the chromatographic parameters of USP “Procedure 2” and using various comprehensive structural elucidation methods such as high resolution tandem mass spectrometry with on-line hydrogen-deuterium (H/D) exchange or two-dimensional nuclear magnetic resonance spectroscopy (NMR) we gained new insights about the complex impurity profile of the synthetic thyroid hormone. This resulted in the characterization of 24 compounds previously unknown to literature and the introduction of two new classes of Levothyroxine Sodium impurities. Five novel compounds were unambiguously identified via isolation or synthesis of reference substances and subsequent NMR spectroscopic investigation. Additionally, Collision-Induced Dissociation (CID)-type fragmentation of identified major impurities as well as neutral loss fragmentation patterns of many characterized impurities were discussed. |
---|---|
ISSN: | 0731-7085 1873-264X |
DOI: | 10.1016/j.jpba.2016.12.002 |